You reviewed ....
for this content
out of 5
Event : Heart Failure 2016
Topic : Other
The association of galectin-3 and clinical parameters in patients with chronic heart failure
Heart Failure 2016
Association between neutrophil gelatinase-associated lipocalin (NGAL) and ventricular function in patients with chagas cardiomyopathy. Nephron or cardiomyocyte?
Low circulating microRNA levels in heart failure patients are associated with peripheral arterial disease
The influence of the standard heart failure treatment on the RDW variation in patients with decompensated heart failure
Influence of body mass index on laboratory and biomarkers in acute heart failure patients
The role of circulating miR-21, miR-34a, miR-423, miR-208a and miR-499a in ischemic and dilated cardiomyopathy
Prognostic value of high sensitivity troponin-T to identify patients at risk of primary graft dysfunction after heart transplantation
Galectin-3 in different phenotypes of heart failure
High-sensitivity troponins are the most effective predictors of mortality after heart transplantation when compared to other cardiac and renal biomarkers
Prognostic utility of ST2 level as a predictor of clinical outcomes in incidental dialysis patients.
Serum neprilysin and recurrent hospitalizations after acute heart failure
Plasma neutrophil gelatinase-associated lipocaline and long-term mortality in acute heart failure
The lymphocyte count and neutrophil/lymphocyte ratio as independent predictors for cardiac events in heart failure only in ischemic heart disease patients
Higher urinary hydrogen peroxide levels are associated with increased plasma renin activity and aldosterone concentration in patients with chronic heart failure
Correlation between N-terminal pro-brain natriuretic peptide levels and myocardial involvement detected with 2D speckle tracking echocardiography in systemic sclerosis
Brain natriuretic peptide guided transthoracic doppler 2D echocardiography requests is cost saving and effective way to rule out heart failure.
Prognostic value of serial b-type natriuretic peptide in hospitalized heart failure patients and mortality
Get your access to resources
Our mission: To reduce the burden of cardiovascular disease